Communicating with patients about harms and risks

PLoS Medicine

Volumn 2, Issue , 2005, Pages 0091-0092

  Herxheimer, Andrew ^a  

^a UK COCHRANE CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

BREAST CARCINOMA; DOCTOR PATIENT RELATION; DRUG EFFICACY; DRUG INFORMATION; EDUCATION PROGRAM; EVIDENCE BASED MEDICINE; HARM REDUCTION; HEALTH CARE COST; HEALTH CARE PERSONNEL; HUMAN; INFORMATION DISSEMINATION; INTERPERSONAL COMMUNICATION; MEDICAL INFORMATION; PATIENT EDUCATION; PATIENT INFORMATION; PHYSICIAN ATTITUDE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SHORT SURVEY; SIDE EFFECT; ARTICLE; DECISION MAKING; HEALTH BEHAVIOR; REPRODUCIBILITY;

COMMUNICATION; DECISION MAKING; HEALTH BEHAVIOR; HUMANS; PHYSICIAN-PATIENT RELATIONS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT;

EID: 15744395046     PISSN: 15491277     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pmed.0020042     Document Type: Short Survey

References (5)

1. Gigerenzer G (2003) Reckoning with risk. London: Penguin Books. 310 p.
2. Hoffrage U, Gigerenzer G (1998) Using natural frequencies to improve diagnostic inferences. Acad Med 73: 538-540.
3. Aronson J, Ferner R (2003) Joining the DoTS: New approach to classifying adverse drug reactions. BMJ 327: 1222-1225.
4. Cuervo LG, Aronson JK (2004) The road to health care. BMJ 329: 1-2.
5. Loke YK (2004) Assessing the benefit-harm balance at the bedside. BMJ 329: 7-8.